Euglycemic diabetic ketoacidosis following major vascular surgery is a new item on the differential for postoperative acidosis
New pharmacologic advances in the treatment of diabetes include SGLT-2 inhibitors, which have been demonstrated in randomized-controlled clinical trials to reduce overall and cardiac-specific mortality and slow progression of chronic kidney disease. Euglycemic diabetic ketoacidosis is a rare but lif...
Saved in:
Main Authors: | Clara M. Gomez-Sanchez, MD, Bian X. Wu, MD, Jeffrey E. Gotts, MD, Robert W. Chang, MD |
---|---|
Format: | article |
Language: | EN |
Published: |
Elsevier
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/3006de9df1f84acda593c0de6bbb7600 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Second line therapy in type 2 diabetes: legacy effect activation
by: Ekaterina A. Shestakova
Published: (2017) -
Acidosis renal y diabetes insípida
by: SILVA,GABRIEL
Published: (1956) -
Encefalomiopatia mitocondrial, acidosis lactica y apariencia de accidentes vasculares cerebrales
by: Mesa L,Tomas, et al.
Published: (1990) -
Ruminal acidosis: strategies for its control
by: Jaramillo-López,Esaúl, et al.
Published: (2017) -
Acidosis tubular renal: Presentación de 2 casos clínicos
by: OCHOA,EDECIA, et al.
Published: (1975)